foxp3 transcription factor staining buffer set Search Results


94
Multi Sciences (Lianke) Biotech Co Ltd foxp3 transcription factor staining buffer kit
Foxp3 Transcription Factor Staining Buffer Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxp3 transcription factor staining buffer kit/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 94 stars, based on 1 article reviews
foxp3 transcription factor staining buffer kit - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
R&D Systems foxp3 transcription factor staining buffer
Foxp3 Transcription Factor Staining Buffer, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxp3 transcription factor staining buffer/product/R&D Systems
Average 90 stars, based on 1 article reviews
foxp3 transcription factor staining buffer - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

97
Cytek Biosciences perm solution
Perm Solution, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perm solution/product/Cytek Biosciences
Average 97 stars, based on 1 article reviews
perm solution - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

90
MultiSciences Biotech Co Ltd foxp3
Remodeling of the immune microenvironment of the chronic wounds in diabetic mice by UCMSCs-exo/eNOS. I: Treatment with PBS. II: Treatment with UCMSCs-exo. III: Treatment with UCMSCs-exo/eNOS. a Immunohistochemistry of CD3 and CD11c in the skin wounds of diabetic mice treated with PBS, UCMSCs-exo, and UCMSCs-exo/eNOS on postoperative day 14. Scale bar: 100 μm. b , c Quantification of immunohistochemical staining of CD3 and CD11c (n = 6 in each group, two-tailed Student’s t-test). d M1 macrophages in the wound tissue. immunofluorescence images of F4/80 and CD86. Scale bar: 100 μm. e M2 macrophages in the wound tissue: immunofluorescence images of F4/80 and CD163. Scale bar: 100 μm. f , g Quantitative immunofluorescence analysis of M1 and M2 macrophages(n = 6 in each group, two-tailed Student’s t-test). h Representative flow cytometry plots of CD25 + <t>Foxp3</t> + Treg cells in wound tissue. i Representative flow cytometry image of CD69 + CD103 + T RM cells in wound tissues. j Quantitative analysis of the proportion of CD25 + Foxp3 + Treg cells in wound tissues (n = 4 in I group, n = 4 in II group and n = 3 in III group, Mann–Whitney U test). k Quantitative analysis of the proportion of CD69 + CD103 + T RM cells in wound tissues (n = 4 in each group, two-tailed Student’s t-test). Data represent means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. PBS group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. UCMSCs-exo group
Foxp3, supplied by MultiSciences Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxp3/product/MultiSciences Biotech Co Ltd
Average 90 stars, based on 1 article reviews
foxp3 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher foxp3/transcription factor staining buffer set
Remodeling of the immune microenvironment of the chronic wounds in diabetic mice by UCMSCs-exo/eNOS. I: Treatment with PBS. II: Treatment with UCMSCs-exo. III: Treatment with UCMSCs-exo/eNOS. a Immunohistochemistry of CD3 and CD11c in the skin wounds of diabetic mice treated with PBS, UCMSCs-exo, and UCMSCs-exo/eNOS on postoperative day 14. Scale bar: 100 μm. b , c Quantification of immunohistochemical staining of CD3 and CD11c (n = 6 in each group, two-tailed Student’s t-test). d M1 macrophages in the wound tissue. immunofluorescence images of F4/80 and CD86. Scale bar: 100 μm. e M2 macrophages in the wound tissue: immunofluorescence images of F4/80 and CD163. Scale bar: 100 μm. f , g Quantitative immunofluorescence analysis of M1 and M2 macrophages(n = 6 in each group, two-tailed Student’s t-test). h Representative flow cytometry plots of CD25 + <t>Foxp3</t> + Treg cells in wound tissue. i Representative flow cytometry image of CD69 + CD103 + T RM cells in wound tissues. j Quantitative analysis of the proportion of CD25 + Foxp3 + Treg cells in wound tissues (n = 4 in I group, n = 4 in II group and n = 3 in III group, Mann–Whitney U test). k Quantitative analysis of the proportion of CD69 + CD103 + T RM cells in wound tissues (n = 4 in each group, two-tailed Student’s t-test). Data represent means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. PBS group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. UCMSCs-exo group
Foxp3/Transcription Factor Staining Buffer Set, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxp3/transcription factor staining buffer set/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
foxp3/transcription factor staining buffer set - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
LabClinics SA foxp3/ transcription factor staining buffer set
Remodeling of the immune microenvironment of the chronic wounds in diabetic mice by UCMSCs-exo/eNOS. I: Treatment with PBS. II: Treatment with UCMSCs-exo. III: Treatment with UCMSCs-exo/eNOS. a Immunohistochemistry of CD3 and CD11c in the skin wounds of diabetic mice treated with PBS, UCMSCs-exo, and UCMSCs-exo/eNOS on postoperative day 14. Scale bar: 100 μm. b , c Quantification of immunohistochemical staining of CD3 and CD11c (n = 6 in each group, two-tailed Student’s t-test). d M1 macrophages in the wound tissue. immunofluorescence images of F4/80 and CD86. Scale bar: 100 μm. e M2 macrophages in the wound tissue: immunofluorescence images of F4/80 and CD163. Scale bar: 100 μm. f , g Quantitative immunofluorescence analysis of M1 and M2 macrophages(n = 6 in each group, two-tailed Student’s t-test). h Representative flow cytometry plots of CD25 + <t>Foxp3</t> + Treg cells in wound tissue. i Representative flow cytometry image of CD69 + CD103 + T RM cells in wound tissues. j Quantitative analysis of the proportion of CD25 + Foxp3 + Treg cells in wound tissues (n = 4 in I group, n = 4 in II group and n = 3 in III group, Mann–Whitney U test). k Quantitative analysis of the proportion of CD69 + CD103 + T RM cells in wound tissues (n = 4 in each group, two-tailed Student’s t-test). Data represent means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. PBS group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. UCMSCs-exo group
Foxp3/ Transcription Factor Staining Buffer Set, supplied by LabClinics SA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxp3/ transcription factor staining buffer set/product/LabClinics SA
Average 90 stars, based on 1 article reviews
foxp3/ transcription factor staining buffer set - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc treg cells (cd4+ foxp3
Effects of P3 infection on DCs-induced differentiation of regulatory T cells . 1 × 10 5 mock-, P3-, UV-P3- or LPS-treated bmDCs were incubated with 1 × 10 6 allogeneic naïve T cells for 5 days. T cells were purified and doubly labeled for <t>CD4</t> and <t>Foxp3,</t> and assessed by FACS. The in vivo <t>Treg</t> in splenocytes were purified and examined by FACS from mice inoculated with 1 × 10 5 PFU P3 or identical UV-P3 i.p. for 5 days. Representative result was shown from three independent experiments (A). The percentage represented the ratio of CD4+ Foxp3+ cells in CD4+ T cells. P3-infected bmDCs elicited the Treg differentiation in vitro (B). After P3 infection or UV-P3 stimulation of mice i.p., Treg differentiation in vivo was analyzed immediately (C). Results were expressed as the means ± SD of triplicates. *, P < 0.05.
Treg Cells (Cd4+ Foxp3, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/treg cells (cd4+ foxp3/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
treg cells (cd4+ foxp3 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Remodeling of the immune microenvironment of the chronic wounds in diabetic mice by UCMSCs-exo/eNOS. I: Treatment with PBS. II: Treatment with UCMSCs-exo. III: Treatment with UCMSCs-exo/eNOS. a Immunohistochemistry of CD3 and CD11c in the skin wounds of diabetic mice treated with PBS, UCMSCs-exo, and UCMSCs-exo/eNOS on postoperative day 14. Scale bar: 100 μm. b , c Quantification of immunohistochemical staining of CD3 and CD11c (n = 6 in each group, two-tailed Student’s t-test). d M1 macrophages in the wound tissue. immunofluorescence images of F4/80 and CD86. Scale bar: 100 μm. e M2 macrophages in the wound tissue: immunofluorescence images of F4/80 and CD163. Scale bar: 100 μm. f , g Quantitative immunofluorescence analysis of M1 and M2 macrophages(n = 6 in each group, two-tailed Student’s t-test). h Representative flow cytometry plots of CD25 + Foxp3 + Treg cells in wound tissue. i Representative flow cytometry image of CD69 + CD103 + T RM cells in wound tissues. j Quantitative analysis of the proportion of CD25 + Foxp3 + Treg cells in wound tissues (n = 4 in I group, n = 4 in II group and n = 3 in III group, Mann–Whitney U test). k Quantitative analysis of the proportion of CD69 + CD103 + T RM cells in wound tissues (n = 4 in each group, two-tailed Student’s t-test). Data represent means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. PBS group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. UCMSCs-exo group

Journal: Journal of Nanobiotechnology

Article Title: Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair

doi: 10.1186/s12951-023-01886-3

Figure Lengend Snippet: Remodeling of the immune microenvironment of the chronic wounds in diabetic mice by UCMSCs-exo/eNOS. I: Treatment with PBS. II: Treatment with UCMSCs-exo. III: Treatment with UCMSCs-exo/eNOS. a Immunohistochemistry of CD3 and CD11c in the skin wounds of diabetic mice treated with PBS, UCMSCs-exo, and UCMSCs-exo/eNOS on postoperative day 14. Scale bar: 100 μm. b , c Quantification of immunohistochemical staining of CD3 and CD11c (n = 6 in each group, two-tailed Student’s t-test). d M1 macrophages in the wound tissue. immunofluorescence images of F4/80 and CD86. Scale bar: 100 μm. e M2 macrophages in the wound tissue: immunofluorescence images of F4/80 and CD163. Scale bar: 100 μm. f , g Quantitative immunofluorescence analysis of M1 and M2 macrophages(n = 6 in each group, two-tailed Student’s t-test). h Representative flow cytometry plots of CD25 + Foxp3 + Treg cells in wound tissue. i Representative flow cytometry image of CD69 + CD103 + T RM cells in wound tissues. j Quantitative analysis of the proportion of CD25 + Foxp3 + Treg cells in wound tissues (n = 4 in I group, n = 4 in II group and n = 3 in III group, Mann–Whitney U test). k Quantitative analysis of the proportion of CD69 + CD103 + T RM cells in wound tissues (n = 4 in each group, two-tailed Student’s t-test). Data represent means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. PBS group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. UCMSCs-exo group

Article Snippet: Staining of intracellular markers, such as the Treg marker FoxP3 (MultiSciences, China), were performed on ice.

Techniques: Immunohistochemistry, Immunohistochemical staining, Staining, Two Tailed Test, Immunofluorescence, Flow Cytometry, MANN-WHITNEY

Effects of P3 infection on DCs-induced differentiation of regulatory T cells . 1 × 10 5 mock-, P3-, UV-P3- or LPS-treated bmDCs were incubated with 1 × 10 6 allogeneic naïve T cells for 5 days. T cells were purified and doubly labeled for CD4 and Foxp3, and assessed by FACS. The in vivo Treg in splenocytes were purified and examined by FACS from mice inoculated with 1 × 10 5 PFU P3 or identical UV-P3 i.p. for 5 days. Representative result was shown from three independent experiments (A). The percentage represented the ratio of CD4+ Foxp3+ cells in CD4+ T cells. P3-infected bmDCs elicited the Treg differentiation in vitro (B). After P3 infection or UV-P3 stimulation of mice i.p., Treg differentiation in vivo was analyzed immediately (C). Results were expressed as the means ± SD of triplicates. *, P < 0.05.

Journal: Virology Journal

Article Title: Japanese Encephalitis Virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cells

doi: 10.1186/1743-422X-8-39

Figure Lengend Snippet: Effects of P3 infection on DCs-induced differentiation of regulatory T cells . 1 × 10 5 mock-, P3-, UV-P3- or LPS-treated bmDCs were incubated with 1 × 10 6 allogeneic naïve T cells for 5 days. T cells were purified and doubly labeled for CD4 and Foxp3, and assessed by FACS. The in vivo Treg in splenocytes were purified and examined by FACS from mice inoculated with 1 × 10 5 PFU P3 or identical UV-P3 i.p. for 5 days. Representative result was shown from three independent experiments (A). The percentage represented the ratio of CD4+ Foxp3+ cells in CD4+ T cells. P3-infected bmDCs elicited the Treg differentiation in vitro (B). After P3 infection or UV-P3 stimulation of mice i.p., Treg differentiation in vivo was analyzed immediately (C). Results were expressed as the means ± SD of triplicates. *, P < 0.05.

Article Snippet: After 5 days of co-culture, in vitro Treg cells (CD4+ and Foxp3+) were isolated (StemCell, Vancouver, BC, Canada) and stained with Mouse Regulatory T Cell Staining Kit (eBioscience Inc., San Diego, CA) in accordance with the manufacturer's instructions and analyzed by FACS.

Techniques: Infection, Incubation, Purification, Labeling, In Vivo, In Vitro